OTC:EMMA | Free Cash Flow | Emmaus Life Sciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$344,000.00
2025-12-31$2.21M$0.00$2.21M
2025-03-31$279,000.00
2024-12-31$343,000.00$6,000.00$337,000.00
2024-03-31$140,000.00$4,000.00$136,000.00
2023-12-31$1.04M$6,000.00$1.03M85.19%
2023-03-31-$1.29M$6,000.00-$1.3M
2022-12-31$1.68M$8,000.00$1.67M834.50%
2022-03-31-$4.73M$2,000.00-$4.74M
2021-12-31$865,000.00$62,000.00$803,000.00
2021-03-31-$4M
2020-12-31$1.91M$2,000.00$1.91M
2020-03-31$1.81M$3,000.00$1.81M32.76%
2019-12-31-$386,000.00$5,000.00-$391,000.00
2019-03-31-$1.18M$16,000.00-$1.2M
2018-12-31-$898,000.00$13,000.00-$911,000.00
2018-09-30-$1.62M$0.00-$1.62M-11.15%
2017-12-31-$2.44M$28,100.00-$2.47M
2017-09-30-$2.12M$40,800.00-$2.16M
2016-12-31-$765,800.00$1,600.00-$767,400.00
2016-09-30-$948,500.00$1,200.00-$949,700.00
2015-12-31-$607,500.00
2015-09-30-$443,800.00
2014-12-31-$783,200.00
2014-09-30-$702,800.00
2013-12-31-$1.06M
2013-09-30-$983,900.00
2012-12-31-$554,700.00
2012-09-30-$366,300.00
2011-12-31-$997,000.00
2010-12-31-$1.18M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$11,000.00$1,000.00-$12,000.00
2024-12-31-$2.29M$12,000.00-$2.3M
2023-12-31-$1.5M$17,000.00-$1.52M
2022-12-31-$5.07M$26,000.00-$5.1M
2021-12-31-$1.25M$73,000.00-$1.33M
2020-12-31-$2.45M$15,000.00-$2.47M-182.13%
2019-12-31-$4.52M$60,000.00-$4.58M
2018-12-31-$5.63M$94,000.00-$5.73M
2018-09-30-$9.04M$55,200.00-$9.09M
2017-09-30-$4.79M$127,900.00-$4.92M
2016-09-30-$2.98M$4,000.00-$2.98M
2015-09-30-$2.16M
2014-09-30-$3.27M
2013-09-30-$3.04M
2012-09-30-$2.34M
2011-09-30-$3.57M
2010-09-30-$4.91M